Press release
Global Aortic Endograft Market to Reach USD 5.78 Billion by 2035 as AI-Driven Endovascular Innovations Transform Vascular Care
The global aortic endograft market, valued at USD 3.59 billion in 2025, is forecast to reach USD 5.78 billion by 2035, growing at a compound annual growth rate (CAGR) of 4.9%. The surge is fueled by a rising prevalence of aortic aneurysms, growing demand for minimally invasive vascular procedures, and rapid advancements in AI-integrated graft design and delivery systems.Aortic endografts-core components of Endovascular Aneurysm Repair (EVAR) and Thoracic Endovascular Aneurysm Repair (TEVAR)-offer less invasive, safer alternatives to traditional open surgery. As patient and physician awareness increases, endovascular interventions are becoming the gold standard in aortic aneurysm management worldwide.
Market Overview (2025-2035)
• Market Size (2025): USD 3,598.4 million
• Forecast Value (2035): USD 5,783.7 million
• Growth Rate: 4.9% CAGR
• Top Product Segment: Abdominal Aortic Grafts
• Leading Procedure: Endovascular Aneurysm Repair (EVAR)
• Primary Growth Regions: North America, Europe, and Asia-Pacific
• Top Companies: Medtronic plc, Cook Medical, W.L. Gore & Associates, Terumo Corporation
Get exclusive access to detailed market statistics and trends - request your free sample report today!
https://www.futuremarketinsights.com/reports/sample/rep-gb-18736
Clinical Innovation Driving Demand
The market's expansion is closely linked to innovations that enhance precision, flexibility, and patient recovery. Key advancements include:
• Branched and Fenestrated Endografts: Designed to treat complex anatomies by accommodating unique vascular structures and improving procedural success rates.
• AI and 3D Imaging Integration: Advanced imaging and artificial intelligence are optimizing graft selection, placement accuracy, and patient-specific customization.
• Bioresorbable and Drug-Eluting Grafts: Emerging technologies that reduce inflammation, minimize restenosis, and improve long-term graft durability.
Together, these developments are transforming vascular care into a personalized, technology-driven discipline-reducing hospital stays, lowering complication risks, and improving quality of life for patients with aortic aneurysms.
Regional Insights
North America:
North America continues to lead the market due to strong healthcare infrastructure, favorable reimbursement policies, and the high prevalence of aortic aneurysms in the aging population. The U.S. has seen a notable increase in EVAR adoption, accounting for nearly three-quarters of aortic repair procedures, supported by robust R&D investments and early screening initiatives.
Europe:
Europe's steady growth is supported by an expanding elderly population and rising healthcare spending. Countries such as Germany, France, and the UK are at the forefront of clinical innovation, aided by government-backed vascular health programs. Regulatory frameworks focused on safety ensure product quality and patient protection, encouraging continued investment in next-generation endografts.
Asia-Pacific:
Asia-Pacific is poised for rapid expansion due to increased healthcare investment, growing incidence of aortic aneurysms, and the adoption of advanced endovascular repair systems in Japan, China, and India. Localized manufacturing and government-supported medical infrastructure programs are improving access to life-saving technologies and lowering costs in developing markets.
Industry Challenges and Opportunities
While the market outlook remains strong, challenges persist:
• High procedural costs and device-related complications limit accessibility in emerging economies.
• Regulatory hurdles and lengthy approval processes slow innovation cycles.
• Specialized surgical training and high-end imaging systems remain prerequisites for successful EVAR and TEVAR procedures.
However, major opportunities are emerging from:
• AI-powered surgical planning and robotic-assisted deployments that improve graft accuracy.
• Hybrid operating rooms combining imaging and surgical capabilities for faster, safer interventions.
• Next-generation graft materials that enhance flexibility, sealing strength, and long-term biocompatibility.
These breakthroughs position the market for sustained growth, particularly in countries modernizing their cardiovascular care systems.
Competitive Landscape
The aortic endograft industry remains moderately consolidated, dominated by a few global leaders:
• Medtronic plc (30-35%) - Offers an extensive portfolio of aortic stent graft systems and leads clinical innovation through continuous R&D.
• Cook Medical (20-25%) - Specializes in both abdominal and thoracic endograft systems, focusing on customization and procedural efficiency.
• W.L. Gore & Associates (15-20%) - Known for durable, flexible endografts with advanced sealing technology.
• Terumo Corporation (8-12%) - Expands its footprint through advanced delivery systems and minimally invasive solutions.
Emerging players such as Endologix LLC, MicroPort Scientific, and CryoLife, Inc. are strengthening competition through localized production, patient-specific devices, and AI-assisted delivery systems. Strategic alliances between device manufacturers and hospital networks are expected to further drive product adoption.
Future Outlook
The next decade will redefine the aortic endograft market through digitally guided surgery, personalized vascular treatment, and hybrid EVAR-TEVAR integration. With AI-enhanced imaging and biodegradable stent grafts entering the market, patient outcomes are expected to reach unprecedented levels of precision and safety.
By 2035, the global market's projected value of USD 5.78 billion underscores not just economic growth-but a transformation in how vascular medicine combines engineering excellence, medical precision, and sustainability to redefine aortic repair.
Purchase Full Report for Detailed Insights
For access to full forecasts, regional breakouts, company share analysis, and emerging trend assessments, you can purchase the complete report here:
Buy Full Report - Aortic Endograft Market
https://www.futuremarketinsights.com/checkout/18736
Have a specific Requirements and Need Assistant on Report Pricing or Limited Budget please contact us - sales@futuremarketinsights.com
Similar Industry Reports
Aortic Stent Grafts Market
https://www.futuremarketinsights.com/reports/aortic-stents-grafts-market
Intra-Aortic Balloon Pump (IABP) Market
https://www.futuremarketinsights.com/reports/intra-aortic-balloon-pump-iabp-market
Thoracic Aortic Aneurysm Market
https://www.futuremarketinsights.com/reports/thoracic-aortic-aneurysm-market
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Aortic Endograft Market to Reach USD 5.78 Billion by 2035 as AI-Driven Endovascular Innovations Transform Vascular Care here
News-ID: 4253644 • Views: …
More Releases from Future Market Insights
Japan's Calcium Gluconate Demand to Reach USD 6.3 Billion by 2035 Driven by Prev …
The demand for calcium gluconate in Japan is projected to rise from USD 4.9 billion in 2025 to USD 6.3 billion by 2035, registering a compound annual growth rate (CAGR) of 2.5%. Calcium gluconate, a calcium salt, is widely used across pharmaceutical and food industries, from intravenous treatments for calcium deficiencies to fortifying foods and beverages.
The growth is primarily driven by the increasing prevalence of calcium-related deficiencies and the expanding…
Japan's Cheese Flavor Demand to Surpass USD 1.29 Trillion by 2035, Driven by Sna …
The demand for cheese flavor in Japan is projected to expand from USD 786.9 billion in 2025 to USD 1,293.8 billion by 2035, advancing at a steady 5.1% CAGR. Growth is anchored in the rising use of cheese flavor systems across snack foods, processed meals, baked goods and seasoning blends-segments where authentic taste delivery and differentiation continue to shape product development strategies nationwide.
Japan's food manufacturing ecosystem is integrating more sophisticated…
Japan's Canned Legumes Demand Set for Steady Growth, Expected to Reach USD 248.2 …
Japan's canned legumes demand is valued at USD 180.7 million in 2025 and is projected to reach USD 248.2 million by 2035, expanding at a 3.2% CAGR. Growth is driven by rising adoption of plant-based proteins, broader use of ready-to-cook ingredients, and strong preference for shelf-stable foods among urban and small households.
Consumption continues to increase as households incorporate canned chickpeas, beans, peas, and mixed legumes into salads, curries, simmered dishes,…
Japan's Demand for Chlorophyll Color Set to Reach USD 22.2 Billion by 2035 as Cl …
Japan's chlorophyll color industry is entering a decade of accelerated transformation, supported by stringent clean-label regulations, rising consumer scrutiny, and rapid reformulation activity across food and beverage categories. The market is valued at USD 9.7 billion in 2025 and is forecast to reach USD 22.2 billion by 2035, expanding at a strong 8.6% CAGR, underscoring its transition from niche natural colorant to a mainstream formulation priority for manufacturers nationwide.
This surge…
More Releases for Aortic
Rising Incidence Of Aortic Aneurysms Fuels Expansion Of Aortic Endograft Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Aortic Endograft Market Size Growth Forecast: What to Expect by 2025?
There has been significant growth in the size of the aortic endograft market in recent years. The market is projected to expand from $3.35 billion in 2024 to $3.52 billion in 2025, corresponding to a compound annual growth…
Intra Aortic Balloon Pumps Market
Intra-aortic balloon pumps (IABP) are medical devices used to support heart function in patients with severe coronary artery disease, heart failure, or other cardiovascular conditions. These devices work by inflating and deflating a balloon placed in the aorta, which helps improve blood flow to the heart and vital organs. IABPs are primarily used in critical care settings, including cardiac surgery, heart attack recovery, and as a bridge to more definitive…
Intra-Aortic Balloon Pump Market Clearly identifies the medical device focus. In …
InsightAce Analytic Pvt. Ltd. announced the addition of new market research report in its portfolio. 'Global Intra-aortic Balloon Pump Market Assessment - Revenue and Volume Forecast, Historic Revenue and Forecast Till 2028
Global Intra-aortic Balloon Pump market report is segmented based on product type, application and geography. Based upon product type Global Intra-aortic Balloon Pump Market is classified as Product iPulse,Corart BP3,Cardiosave, CS,Corart BP3, ULTRA 7FR,Sensation Catheter ,LINEAR Catheter ,MEGA Catheter
Get…
Aortic Aneurysm Market - Transforming the Aortic Aneurysm Landscape: Redefining …
Newark, New Castle, USA: The "Aortic Aneurysm Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Aortic Aneurysm Market: https://www.growthplusreports.com/report/aortic-aneurysm-market/8565
This latest report researches the industry structure, sales,…
Rising Prevalence of Aortic Aneurysms Driving the Aortic Intervention Market
The global 𝐀𝐨𝐫𝐭𝐢𝐜 𝐈𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧 market is estimated to attain a significant valuation by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand during the forecast period, 2021 - 2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the Aortic Intervention industry. The current…
Aortic Stents Grafts Market: Rising Prevalence of Aortic Aneurysm to Fuel the Gr …
The Aortic Stents Grafts Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well.
View Report - https://www.theinsightpartners.com/reports/aortic-stent-graft-market/
Aortic Stents Grafts is a new option for treatment of…
